Aspirin and Cancer Risk
- PMID: 27533744
- DOI: 10.1001/jamaoncol.2016.2332
Aspirin and Cancer Risk
Comment on
-
Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer.JAMA Oncol. 2016 Jun 1;2(6):762-9. doi: 10.1001/jamaoncol.2015.6396. JAMA Oncol. 2016. PMID: 26940135 Free PMC article.
Similar articles
-
Aspirin and Cancer Risk.JAMA Oncol. 2016 Oct 1;2(10):1371. doi: 10.1001/jamaoncol.2016.2311. JAMA Oncol. 2016. PMID: 27533621 No abstract available.
-
Aspirin and Cancer Risk.JAMA Oncol. 2016 Oct 1;2(10):1370-1371. doi: 10.1001/jamaoncol.2016.2308. JAMA Oncol. 2016. PMID: 27533476 No abstract available.
-
Aspirin and Cancer Risk.JAMA Oncol. 2016 Oct 1;2(10):1370. doi: 10.1001/jamaoncol.2016.2305. JAMA Oncol. 2016. PMID: 27533285 No abstract available.
-
The anti-tumor effect of aspirin: What we know and what we expect.Biomed Pharmacother. 2017 Nov;95:656-661. doi: 10.1016/j.biopha.2017.08.085. Epub 2017 Sep 4. Biomed Pharmacother. 2017. PMID: 28881293 Review.
-
Chemopreventive effects of aspirin at a glance.Biochim Biophys Acta. 2015 Apr;1855(2):254-63. doi: 10.1016/j.bbcan.2015.03.007. Epub 2015 Apr 2. Biochim Biophys Acta. 2015. PMID: 25842298 Review.
Cited by
-
Triptolide-Assisted Phosphorylation of p53 Suppresses Inflammation-Induced NF-κB Survival Pathways in Cancer Cells.Mol Cell Biol. 2017 Jul 14;37(15):e00149-17. doi: 10.1128/MCB.00149-17. Print 2017 Aug 1. Mol Cell Biol. 2017. PMID: 28533220 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources